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BACKGROUND: Long-term results from the International Subarachnoid Hemorrhage
Trial (ISAT) and Barrow Ruptured Aneurysm Trial (BRAT) indicate considerably higher
retreatment rates for aneurysms treated with coiling compared to clipping, but do not
report the outcome of retreatment.
OBJECTIVE: To evaluate retreatment related outcomes.
METHODS: A meta-analysis in accordance with PRISMA guidelines was conducted using
Medline search engines PubMed and EMBASE to identify articles describing outcomes
after retreatment for intracranial aneurysms. Pooled prevalence rates for complete
occlusion rate and mortality were calculated. Outcomes of different treatment and
retreatment combinations were not compared because of indication bias.
RESULTS: Twenty-five articles that met the inclusion criteria were included in the meta-
analysis. Surgery after coiling had a pooled complete occlusion rate of 91.2% (95% confi-
dence interval [CI]: 87.0-94.1) and a pooled mortality rate of 5.6% (95% CI: 3.7-8.3). Coiling
after coiling had a pooled complete occlusion rate of 51.3% (95% CI: 22.1-78.0) and a
pooled mortality rate of 0.8% (95% CI: 0.15-3.7). Surgery after surgery did not provide
a pooled estimate for complete occlusion as only one study was identified but had a
pooledmortality rate of 5.9% (95% CI: 3.1-11.2). Coiling after surgery had a pooled complete
occlusion rate of 56.1% (95% CI: 11.4-92.7) and a pooled mortality rate of 9.3% (95% CI: 4.1-
19.9). All pooled incidence rates were produced using random-effect models.
CONCLUSION: Surgical retreatment was associated with a high complete occlusion rate
but considerablemortality. Conversely, endovascular retreatmentwas associatedwith low
mortality but also a low complete occlusion rate.
KEYWORDS: Subarachnoid hemorrhage, Cerebral aneurysm, Retreatment, Meta-analysis, Coiling, Clipping
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T he current mainstay treatment modal-ities for both ruptured and unrupturedintracranial aneurysms are microsurgical
clipping and endovascular treatment such as
coiling .1,2 There is a growing preference to treat
intracranial aneurysms with an endovascular
treatment modality, as short-term and medium-
long-term outcomes seem to show a superi-
ABBREVIATIONS: CI, confidence interval; GOS,
Glasgow Outcome Scale; ISAT, International
Subarachnoid Hemorrhage Trial; mRS, modified
Rankin Scale; NOS, Newcastle Ottawa Scale;
PRISMA, Preferred Reporting Items for Systematic
Reviews and Meta-Analyses
Supplemental digital content is available for this article at
www.neurosurgery-online.com.
ority over clipping with regard to morbidity,
mortality, and functional outcomes.1-4 Endovas-
cular treatment is also considered to be less
invasive and is suggested to be preferred by
most patients.1-4 However, regrowth and subse-
quent retreatment rate are considerably higher
in patients treated with coiling compared to
clipping in the long term (BRAT 6-yr follow-
up data: retreatment: 16.4% for coiling vs
4.6% for clipping, respectively).2 Furthermore,
the results from the International Subarachnoid
Hemorrhage Trial (ISAT) indicate significantly
higher rates of rebleeding and retreatment rates
for endovascular-treated aneurysms compared to
surgically treated aneurysms at 10-yr follow-
up (retreatment: 17.4% for coiling vs 3.9%
for clipping, respectively).1,5 However, there
was no significant difference in mortality and
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FIGURE 1. Flowchart of the study selection process.
functional outcome, which may indicate that regrowth does
not result in worse outcomes.1,5 Therefore, questions remain
regarding possibility, efficacy, and safety of retreatment after
regrowth as a result of the often-occurring regrowth of aneurysms.
For instance, aneurysms may be difficult to surgically retreat
because of increased mass, scar tissue, and may even require a
bypass.6
One meta-analysis indicated that microsurgical retreatment
may be considered safe.7 However, this meta-analysis was limited
by the studies included. Furthermore, other treatment and
retreatment combinations were subjected to a meta-analysis.7
In addition, different treatment and retreatment combinations
have not been compared. There is a great variety of initial
treatment options which include: clipping, coiling, Pipeline
Embolization Device (PED, C©Chestnut Medical, Medtronic Inc,
Dublin, Ireland), surgical (high-flow) bypass, wrapping, and
trapping, Woven Endobridge (WEB, C©Sequent Medical Inc,
MicroVention Inc, Aliso Viejo, California) device, all of which can
be used for retreatment.6,8-12 The aim of this meta-analysis was to
evaluate the efficacy and safety of retreatment of intracranial
aneurysms for all available treatment-retreatment combinations.
METHODS
Study Selection
A systematic review and meta-analysis of available literature was
performed in accordance with the Preferred Reporting Items for
Systematic Reviews andMeta-Analyses (PRISMA) guidelines.13 PubMed
and Embase databases were searched through October 2017 for
studies reporting outcomes of re-intervention for intracranial aneurysms
(Figure 1). The search syntax was drafted with Appropriate Medical
Subject Headings (MeSH) and Emtree terms for PubMed and Embase,
respectively (Table, Supplemental Digital Content 1). The search was
not limited by date of publication. Duplicates in identified articles were
removed using Endnote X7.5 (Clarivate Analytics, Philadelphia, Pennsyl-
vania). All abstracts were screened in duplicate and discrepancies between
reviewers were resolved by a senior author. Articles that were selected
for full-text review were evaluated by two authors. Reference lists were
checked for possible additional articles.
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Inclusion Criteria
All studies that were screened full-text were included if the following
inclusion criteria were met: (1) the study was original and written in
English or Dutch, (2) the study included a treatment retreatment combi-
nation arm that consisted of a minimum of 10 patients, (3) the study
was conducted in an adult population, (4) the study had been subjected
to peer-review, and (5) the study-reported outcomes of retreatment for
intracranial aneurysms.Only themost recent study was included if results
from a series of patients had been reported in multiple articles.
Data Extraction and Study Quality Assessment
All included studies were evaluated for the following study charac-
teristics: continent, year of publication, sample size, study design,
and follow-up (months). The following population characteristics were
extracted for the initial treatment and retreatment combinations:
mean age (years), number of females and males, initial presentation
(subarachnoid hemorrhage or incidental), initial treatment modality,
retreatment modality, indication for initial treatment, indication
for retreatment, aneurysm location, percentage of initial successful
occlusion, mean total aneurysm size at retreatment, number of large
aneurysms (1.0-2.5 cm), number of giant aneurysms (>2.5 cm), and
mean time to retreatment (months). The following outcomes were
extracted: percentage of complete occlusion on imaging (angiogram
or computed tomography angiography), number of patients that died
within 30 d after surgery (regardless of reason), and clinical outcome
(modified Rankin Scale [mRS] or Glasgow Outcome Scale [GOS]).14,15
Clinical outcomes were only extracted if the patients’ status before and
after the retreatment procedure was documented and had less than
10% missing values. A good clinical outcomes score was defined as
less than 3 and greater than 4 on the mRS and GOS, respectively.14,15
The extraction of the study characteristics and outcomes was performed
by two independent investigators and discrepancies were solved by
discussion or consultation of senior authors. All included studies were
also evaluated for study quality using the Newcastle Ottawa Scale
(NOS).16 Comparability was not scored for studies that did not have
a comparison group. Again, discrepancies were solved by consultation of
senior authors.
Meta-Analysis
The meta-analysis was conducted using R 3.4.2 (The R Foundation,
Vienna, Austria) with use of the “meta” package, which is partially built
on the “Metafor” package.17,18 Pooled prevalence ratios of complete
occlusion rate and mortality rate were calculated using both fixed-
and random-effect models for the following treatment and re-treatment
combinations: surgery after coiling, coiling after coiling, coiling after
surgery, surgery after surgery, PED (Medtronic) after coiling, and PED
after PED. Forest plots were created for the outcomes complete occlusion
rate and mortality rate. The different initial treatment and retreatment
combinations were not directly compared because of indication bias.
The Cochran’s Q test (P < .10) and I2 statistic (I2 value > 50%
was considered significant) were used to evaluate possible hetero-
geneity among the included studies.19 Meta-regression was applied to
identify sources of heterogeneity for the following study character-
istics: continent, year of publication, NOS-score, percentage of females,
mean age (years), percentage of patients that initially presented with
a subarachnoid hemorrhage, percentage of initial successful treatment,
mean total aneurysm size at retreatment, percentage of patients with an
aneurysm located in the posterior circulation, percentage of patients with
large or giant aneurysms, and mean time to re-intervention (months).
Meta-regression separately was applied to all study characteristics and
was only possible if a minimal of 3 studies were included in a specific
treatment retreatment analysis and if no missing values were among the
study characteristics and Bonferroni correction was applied to correct for
multiple testing (critical P-value: .004 based on 13 degrees of freedom).
Publication bias was evaluated by constructing Funnel plots, Eggers’s
linear regression test, and the Begg’s and Mazumdar rank correlation test
(P-value < .05 was considered significant).20,21
RESULTS
The search strategy yielded 4529 studies after removal of dupli-
cates (Figure 1). Twenty-five unique studies were included in the
meta-analysis to evaluate outcomes of first retreatment for intrac-
erebral aneurysms.5,6,9-12,22-40
Baseline Characteristics
The 25 studies reported the outcomes in 1064 patients
(Table 1). The median of mean age of the populations was 50.6 yr
at time of retreatment and the median of mean female percentage
of the populations was 65.0. The studies had a mean follow-
up of 22.9 mo. Regarding aneurysm characteristics, the median
of mean percentage of patients that initially presented with a
subarachnoid hemorrhage was 75.9%. The median of mean
percentage of posterior location was 10.3%. The median of mean
size at retreatment was 7.0 mm, median of mean percentage of
large aneurysms was 18.3%, and the median of mean percentage
of giant aneurysms was 4.4%. Regarding the retreatment, the
median of mean number of months to retreatment was 20.8.
Early retreatment (within the first month) occurred in 6.0% of
cases (median of mean percentage). The NOS score did not
vary greatly among the studies as most were retrospective case
series and cohort studies that did not make comparison between
the different treatment retreatment combinations, except for the
ISAT.5
Thirteen studies evaluated outcomes of surgery after
coiling,6,11,22,24,28,29,31,33,34,36,38-40 3 studies evaluated out-
comes of coiling after coiling,6,26,37 4 studies evaluated
coiling after surgery,9,27,32,35 3 studies evaluated surgery after
surgery,9,12,34 2 studied evaluated PED after coiling,23,30 and 2
studies evaluated PED after PED (Medtronic Inc).10,25
In studies that described outcomes of surgery after coiling,
extrusion of coils and coil compaction were observed in 18.8%
and 30.5% of cases, respectively. Coils were extracted in 22.7%
of cases and intraoperative rupture occurred in 5.6% of cases.
Clipping was performed in 89.2% of cases, a bypass procedure
was performed in 4.6% of cases, wrapping in 4.3% of cases,
trapping in 3.6% of cases, and parent artery occlusion in 1.4%
of cases.
Complete Occlusion
Complete occlusion rates varied considerably among
the treatment retreatment combinations (Table 2). Pooled
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TABLE 2. Outcomes by Study
Clinical outcomea









(n/N (%)) Good Bad Good Bad
Surgery after Coiling Campi et al (2007)5 NA NA 19/22 3/21 17/22 5/22
Chung et al (2010)22 NA 0/29 (0.0) 18/22 4/22 21/22 1/22
Daou et al (2016)11 108/111 (97.3) 3/111 (2.7) NA NA NA NA
Dorfer et al (2012)6 45/52 (86.5) 1/52 (1.9) NA NA NA NA
Gurian et al (1995)24 NA 3/21 (14.3) NA NA NA NA
Klein et al (2008)28 13/13 (100.0) 0/13 (0.0) NA NA NA NA
Konig et al (2007)29 10/10 (100.0) 0/10 (0.0) NA NA NA NA
Lejeune et al (2008)31 19/21 (90.5) 0/21 (0.0) 21/21 0/21 19/21 2/21
Nakamura et al (2013)33 15/15 (100.0) 1/15 (6.7) NA NA NA NA
Owen et al (2015)34 65/73 (89.0) 3/73 (4.1) NA NA NA NA
Romani et al (2011)36 77/81 (95.1) 6/81 (7.4) NA NA NA NA
Veznedaroglu et al (2004)38 15/18 (83.3) NA NA NA NA NA
Wang et al (2017)39 16/19 (84.2) 1/19 (5.3) NA NA NA NA
Zhang et al (2003)40 NA 3/38 (7.9) NA NA NA NA
Coiling after Coiling Campi et al (2007)5 NA NA 53/65 12/65 52/65 13/65
Dorfer et al (2012)6 50/75 (66.7) 0/75 (0.0) NA NA NA NA
Kang et al (2006)26 11/32 (34.4) 0/32 (0.0) NA NA NA NA
Teleb et al (2014)37 NA 0/111 (0.0) NA NA NA NA
Coiling after surgery Campi et al (2007)5 NA NA 6/6 0/6 4/6 1/6
Hokari et al (2016)9 NA 0/10 (0.0) 9/10 1/10 8/10 2/10
Li et al (2013)32 9/31 (29.0) 2/31 (6.5) NA NA NA NA
Owen et al (2015)34 NA 0/4 (0.0) NA NA NA NA
Rabinstein et al (2003)35 17/21 (81.0) 3/21 (14.3) NA NA NA NA
Kim et al (2010)27 NA NA 19/19 0/19 16/19 3/19
Surgery after surgery Hokari et al (2016)9 NA 0/13 (0.0) 12/13 1/13 10/13 3/13
Owen et al (2015)34 NA 2/20 (10.0) NA NA NA NA
Drake et al (1984)12 102/115 (88.7) 6/115 (5.2) NA NA NA NA
PED after surgery Kuhn et al (2017)30 3/6 (50.0) 0/6 (0.0) 5/6 1/6 5/6 1/6
Daou et al (2015)23 23/32 (71.9) 0/32 (0.0) NA NA NA NA
PED after PED Heiferman et al (2017)25 9/19 (47.4) 0/19 (0.0) NA NA NA NA
Fischer et al (2011)10 20/30 (66.7) 0/30 (0.0) 86/88 2/88 81/88 7/88
PED after coiling Kuhn et al (2017)30 8/11 (72.7) 0/14 (0.0) 17/18 1/18 17/18 1/18
PED: Pipeline embolization device; NA: not available.
aGood outcome was defined as mRS < 3 or a GOS > 4.
prevalence rates for complete occlusion were 91.2% (95%
confidence interval [CI]: 87.0-94.2) for surgery after coiling,
51.3% (95% CI: 22.1-78.0) for coiling after coiling, 72.1%
(95% CI: 57.0- 83.3) for PED after coiling, 56.1% (95% CI:
11.4-92.7) for coiling after surgery, and 58.2% (95% CI: 39.0-
75.2) for PED after PED, respectively (Random-effect model,
Figure 2, Table, Supplemental Digital Content 2). Fixed-effect
models yielded similar results. It was not possible to calculate a
prevalence rate for surgery after surgery as only one study was
available for analysis, which reported a complete occlusion rate
of 89%.12
The treatment retreatment combinations coiling after coiling
and coiling after surgery came with considerable heterogeneity
(88.9% and 91.5%, respectively). No significant sources of
heterogeneity were identified for surgery after coiling using meta-
regression after correction for multiple testing. Meta-regression
for other treatment and retreatment combination was not possible
due to the low number of studies included in the analysis. It
was only possible to evaluate publication bias in the surgery after
coiling treatment retreatment combination, which was insignif-
icant, as the other analysis had too few studies to evaluate publi-
cation bias.
Mortality
Similar to complete occlusion rates, the pooled prevalence rates
of mortality varied considerably among the treatment retreatment
combinations (Table 2). Pooled mortality rates for mortality
were 5.6% (95% CI: 3.7-8.3) for surgery after coiling, 0.8%
(95% CI: 0.15-3.7) for coiling after coiling, 2.2% (95% CI:
0.3-14.3) for PED after coiling, 5.9% (95% CI: 3.1-11.2) for
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FIGURE2. Forest plot of pooled prevalence rate of complete occlusion by treatment retreatment population. Forest
plot for prevalence rate of complete occlusion are shown by treatment and retreatment combination. Solid squares
represent the point estimate of each study and the diamond represents the pooled estimate of the prevalence rate.
The I2 value for heterogeneity is shown.
surgery after surgery, 9.3% (95% CI: 4.1-19.9) for coiling after
surgery, and 2.0% (95%CI: 0.3-12.9) for PED after PED, respec-
tively (Random-effect model, Figure 3, Table, Supplemental
Digital Content 2). Fixed-effect models showed similar results.
All the intervention retreatment combinations came with low
heterogeneity (I2 = 0.0% for all studies). With regard to publi-
cation bias, the pooled prevalence rate of mortality for surgery
after coiling may be subject to publication bias (Egger’s test
P-value: .08). However, the Funnel plot indicated no publi-
cation bias (not shown), the trim and fill method yielded a
similar pooled prevalence rate (pooled prevalence rate: 0.8%, 95%
CI: 0.2-3.7), and the Begg’s test indicated no significant publi-
cation bias (P = .12). It was not possible to evaluate publication
bias for the surgery after surgery, PED after coiling, and PED after
PED treatment retreatment combinations due to a low number
of studies included in the analysis.
For surgery after coiling, only publication year was identified as
a potential source of heterogeneity (estimate: –0.06, P-value: .04),
but this association did not remain significant after correction for
multiple testing. Meta-regression for other treatment retreatment
combinations was not possible due to the low number of studies
included in the analysis.
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FIGURE 3. Forest plot of pooled prevalence rate of mortality by treatment retreatment population. Forest
plot for prevalence rate for mortality are shown by treatment and retreatment combination. Solid squares
represent the point estimate of each study and the diamond represents the pooled estimate of the prevalence
rate. The I2 value for heterogeneity is shown.
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Functional Outcomes
Contrary to the occlusion rates or mortality rates,
the functional outcomes were not reported consistently
(Table 2).5,9,10,22,27,30,31 The clinical improvement or deterio-
ration after the second intervention varied considerably among
the treatment retreatment combinations. In general, no large
differences were seen in functional outcome before and after
intervention between the different treatment and retreatment
combinations.
DISCUSSION
This meta-analysis aimed to evaluate outcomes of retreatment
of intracranial aneurysms. Overall, aneurysms retreated with
surgery showed a high rate of complete occlusion. However, this
came with a relatively high pooled prevalence rate of mortality.
Contrarily, intracranial aneurysms retreated with coiling or a
PED (Medtronic) have a relative low complete occlusion rate,
but also a low pooled prevalence rate of mortality. Functional
outcomes were reported very infrequently and did not show
a great variation between the different treatment retreatment
combinations. The overall quality of the studies was low, as no
prospective studies were available, except for the ISAT, which only
reported functional outcomes.5
The occlusion rate for surgically retreated patients appears
to be high based on the results of our meta-analysis. One
other meta-analysis suggested an occlusion rate of 98.3%.7
One systematic review evaluating outcomes of surgically treated
aneurysms concluded an occlusion rate of 93%.8 These outcomes
are broadly similar to the findings in this meta-analysis. One series
that evaluated outcomes of 2360 intracranial aneurysm patients,
initially treated with endovascular approaches, found that 350
(12.3%) patients required endovascular retreatment and reported
a complete occlusion rate of only 46.9% after the second session of
coiling.41 Furthermore, 94 patients required three or more coiling
sessions with a complete occlusion rate of 35.6% (maximum of
9 sessions, n = 1).41 The potential necessity of multiple subse-
quent recoiling sessions may emphasize the need from complete
initial occlusion of aneurysms. The latter study was not included
in this meta-analysis as the initial endovascular treatment was
preceded by various microsurgical procedures in some patients.41
However, incomplete coiling is not the only factor associated with
regrowth as increased total aneurysm size, packing density, older
age, male sex, hypertension, and ruptured aneurysm have also
been associated with aneurysm regrowth after coiling in retro-
spective analyses.42-44
The mortality rate seems to be high in patients that received
surgical retreatment based on our meta-analysis. Another meta-
analysis suggested that mortality may actually be 0% (95%
CI= 0.0%-2.5%).7 One other review reported a mortality preva-
lence of 3.6% for aneurysms that were surgically retreated after
initial endovascular occlusion, which is similar to the findings in
this meta-analysis.8 One explanation for the mortality in surgi-
cally retreated patients rate may be the necessity of trapping,
wrapping, ligation, or a bypass, which was necessary in 1.9%,
2.7%, 1.8%, and 2.1% of cases, respectively, which is largely
similar to the findings of this study.8 Another explanation may
also be mortality due to non-procedural complications or presen-
tation with a rebleed, as was seen in the cohort described by
Romani et al.36 One large series investigating multiple recoiling
sessions in 350 patients reported a morbidity rate of 2.2% and
only had one mortality.41 Coiling after surgery was associated
with a relatively high mortality, but this was probably the result of
rebleed related complications in the two studies that had mortal-
ities.32,35
The high mortality and poor occlusion rates for surgical
retreatment and endovascular retreatment, respectively, show
the importance of treatment modality selection when patients
initially present with intracranial aneurysms. Initial coiling may
be preferable because of lower morbidity and less invasive
nature if no additional retreatment is to be expected.5 The
necessity for retreatment after coiling is approximately three to
four times higher than after microsurgical clipping based on
two randomized control trials (RCTs).2,5 Therefore, patients
that require surgery after coiling would probably not have
needed a secondary procedure if surgery had been the primary
treatment modality. Furthermore, recoiling may increase the
size of the aneurysm with every additional placement of coils
due to its low success rate. The difficulty of surgical treatment
of previously coiled aneurysms probably increases after every
recoiling session as the aneurysm increases in size. Similarly,
the complete occlusion rate appears to go down with every
subsequent recoiling procedure.41 Although this does not seem
to result in mortality for patients, rebleeding rates could be
higher and patients may develop symptoms as the result of
mass-effect from the aneurysm.41,45,46 Currently, no prospective
and comparative outcomes are known for retreated intracranial
aneurysm and little is known on factors that contribute to
regrowth.
This is the first meta-analysis that evaluated the outcomes of
retreatment for intracranial aneurysms and was conducted in
accordance with PRISMA guidelines.13 This meta-analysis also
evaluated all available intervention and retreatment combina-
tions. However, this meta-analysis is limited by several factors.
The available studies from the literature were of poor quality,
based on the NOS-scale. All studies were retrospective in nature
and generally had a small sample size and limited follow-up.
There was little consistency with regard to reported outcomes as
most studies only consistently reported mortality and complete
occlusion rate, which was why nometa-analysis was conducted for
functional outcomes. The limited reporting on baseline charac-
teristics and outcomes of specific subgroups such as patients
that initially presented with a subarachnoid hemorrhage did not
allow for further subgroup analyses. Authors were not contacted
to provide the necessary information due to the great many
studies that did not present this information. This especially
holds serious implications for mortality as other unevaluated
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factors such as the number of patients presenting with a rebleed
and nonprocedure related complications may influence mortality.
The number of studies could also be considered low for the
respective treatment retreatment combinations (eg only two
studies reporting on outcomes of coiling after coiling were
included). This is partially the result of the inclusion criteria
of a minimum of 10 patients per arm and that only outcomes
of first retreatment were evaluated. There was also considerable
heterogeneity among various outcomes for which it was often not
possible to identify contributing factors due to a low number
of studies and variation in reporting of base-line character-
istics by meta-regression. No comparison was made between the
different treatment and retreatment combinations with regard to
outcomes because of indication bias. It was also not possible to
study the effect of timing of retreatment in relation to outcomes
as timing was rarely reported. Meta-regression was also only
applied for individual study characteristics and was often not
possible due to the low number of studies and variation in
reporting. Furthermore, none of the associations identified using
meta-regression remained significant after correction for multiple
testing. Findings of this meta-analysis were not validated in
internal dataset with cross validation or in an external dataset as
these were not available.
Knowledge of the outcomes of retreatment could be expanded
by prospective evaluation of outcomes. A potential trial design
could be a prospective registry that evaluates outcomes of
intracranial aneurysms irrespective of initial treatment. This could
both provide insight into which aneurysms require retreatment on
the long term, how the necessity of retreatment can be avoided,
and what retreatment strategy results in superior outcomes. The
outcomes of such a registry could also prediction model to aid
clinical decision-making and improve outcomes of intracranial
aneurysm patients.
CONCLUSION
Surgical retreatment of intracranial aneurysms may be
associated with relatively high occlusion rates but also a relatively
high mortality. Contrarily, secondary coiling may be associated
with relatively lower mortality but also with low rates of complete
occlusion. Outcomes of this meta-analysis should be inter-
preted with caution due to various limitations. Nevertheless, the
outcomes from this meta-analysis could potentially stress the
need for complete initial treatment of intracranial aneurysms
to prevent the retreatment. The findings of this meta-analysis
could also potentially strengthen the argument for opting to
clip an intracranial aneurysm when initial coiling may not result
in complete occlusion. Further knowledge on what contributes
to regrowth of coiled aneurysm is needed to optimize initial
treatment selection for individual patients.
Disclosure
The authors have no personal, financial, or institutional interest in any of the
drugs, materials, or devices described.
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COMMENTS
I n this present meta-analysis, the authors amassed a cohort of1064 patients with previously treated aneurysms who consequently
underwent retreatment with a variety of surgical and endovascular
modalities. As might be expected, microsurgical treatment was found
to have high rates of aneurysm occlusion (91% and 89% after previous
coiling and surgery, respectively). However, retreatment with surgery was
associated with higher periprocedural mortality, compared to endovas-
cular techniques. In contrast, meta-analysis of endovascular retreatment
modalities illustrated high heterogeneity in results, with occlusion rates
varying greatly between individual studies and also between retreatment
categories (ie, coiling versus flow-diversion).
Using a broad swath of published literature, this meta-analysis
confirms the inherent risks of both surgical and endovascular aneurysm
retreatment. Furthermore, as the previously established standard, micro-
surgical techniques are relatively consistent in providing good overall
occlusion rates after retreatment. In contrast, endovascular therapy (both
coiling and flow-diversion) represents a more contemporary retreatment
option, and thus may have lower occlusion rates and a wider variance in
success given the inherent learning curve.
While this study incorporates a large patient population with a
relatively rare pathology, the overall meta-analysis should be considered in
light of its numerous limitations. First, the individual studies included in
analysis are highly heterogeneous in methodology, results, and outcomes,
such that only occlusion rates and mortality could be assessed. Second,
the majority of studies were either retrospective case series or cohort
analysis, both of which may be methodologically biased. Lastly, in most
comparison categories two or fewer studies were cumulatively assessed
(coiling after coiling, PED [Medtronic] after coiling, coiling after surgery,
surgery after surgery, and PED after PED), again perhaps biasing the
overall statistical analysis.
Nonetheless, limitations considered, this manuscript represents a
valuable assessment of an otherwise important debate within the neuro-
surgical field. Furthermore, it suggests the need for more high quality
evidence in aneurysm retreatment strategies.
Kurt Yaeger
J. Mocco
New York, New York
A lthough previous prospective studies have reported a significantlyhigher need for retreatment of aneurysms after coiling when
compared to microsurgical clipping,1,2 the specific outcomes of these
retreatment procedures are rarely reported. In this paper, the authors
present a meta-analysis of the literature specifically regarding outcomes of
aneurysm retreatment. Twenty-five articles reporting outcomes in 1064
patients were included with results being categorized based on both initial
treatment and retreatment modality. The highest pooled rate of complete
occlusion was found with surgery after coiling (91.2%), and lower pooled
complete occlusion rates were evident for coiling after coiling (51.3%),
coiling after surgery (56.1%), PED (Medtronic) after coiling (72.1%),
and PED after PED (58.2%). No pooled analysis was performed for
surgery after surgery, as only one study was included, with an occlusion
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rate of 89%. Although surgery after prior coiling was found to have
the highest rate of subsequent complete occlusion, it was also found to
have a relatively high pooled mortality rate of 5.6%. Additional pooled
mortality rates were 0.8% for coiling after coiling, 2.2% for PED after
coiling, 2.0% for PED after PED, 5.9% for surgery after surgery, and
9.3% for coiling after surgery. Functional outcomes were not reported
consistently within the selected studies and therefore were not included
in the meta-analysis.
Selecting a secondary treatment modality for a previously treated
aneurysm is a complex process based on numerous radiographic and
clinical characteristics (eg, aneurysm size, aneurysm location, remnant
morphology, patient age, patient comorbidities, etc). In this study,
outcomes were reported separately with regard to initial treatment and
retreatment modality, and thus serve as a useful summary of existing
literature. However, it is important to note that these subgroups cannot
be directly compared in terms of outcome given the inherent indication
bias. Nonetheless, a few concepts seem to be generally supported by the
data:
1. Similar to the outcomes after initial clipping, surgery as
a treatment modality results in high occlusion rates at time of
re-treatment.
2. Despite the imperfect occlusion rates with endovascular re-
treatment modality, the risk in terms of mortality is generally low,
although interestingly the highest mortality rate was seen in the coiling
after surgery group; the authors surmise that this is likely related to
aneurysmal rebleeding rather than procedure-related complications.
3. Retreatment is not without risk, and therefore aneurysm recur-
rence and retreatment should routinely be included as a relevant endpoint
in outcome studies evaluating new aneurysm treatment modalities or
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